Humanigen Inc., a biopharmaceutical company focused on treating and preventing an uncontrollable inflammatory response by the immune system known as “cytokine storm,” confirmed that lenzilumab…
November 27, 2024
Humanigen Inc., a biopharmaceutical company focused on treating and preventing an uncontrollable inflammatory response by the immune system known as “cytokine storm,” confirmed that lenzilumab…